Brief: Conmed Q4 Adjusted EPS USD 1.34 Vs. IBES Estimate USD 1.2
Feb 05 (Reuters) - Conmed Q4 EPS USD 1.08. * Q4 income from operations USD 52.499 million vs. IBES estimate USD 57.5 million * Q4 net income USD 33.754 million * Q4 sales USD 345.944 million vs. IBES estimate USD 341 million * Q4 pretax profit USD 43.642 million vs. IBES estimate USD 48.2 million * outlook FY adjusted EPS USD 4.25-4.4
Recent news on Conmed
See all newsU.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Conmed Corp reports results for the quarter ended June 30 - Earnings Summary
Conmed Q2 sales, adjusted profit beat on organinc platform growth
Brief: Conmed Q2 Adjusted EPS USD 1.38 Vs. IBES Estimate USD 1.11
Brief: Conmed Is Said To Weigh Sale After Takeover Interest- Bloomberg News